HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway.

Abstract
The intracellular fate of liposomes administered intracardially was examined in the liver and spleen of hamsters experimentally infected with Leishmania donovani. Separate groups of animals were treated with liposomes containing either an antileishmanial agent, a colloidal gold marker, or saline. Ultrastructural examinations of lysosomal interactions with the parasitophorous vacuole and with phagocytized liposomes were made. Lysosomes readily fused with the parasitophorous vacuoles but appeared to have little effect on the parasite, possibly due to the production of enzyme inhibitors. Liposomes rapidly became localized in lysosomes subsequent to endocytosis by macrophages. Morphologic evidence suggested that secondary lysosomes containing liposomal residues then fused with the parasitophorous vacuole. Aspects of one possible pathway are discussed which may account for the greatly enhanced effectiveness of liposomal chemotherapy for experimental visceral leishmaniasis.
AuthorsJ S Weldon, J F Munnell, W L Hanson, C R Alving
JournalZeitschrift fur Parasitenkunde (Berlin, Germany) (Z Parasitenkd) Vol. 69 Issue 4 Pg. 415-24 ( 1983) ISSN: 0044-3255 [Print] Germany
PMID6624193 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Liposomes
  • Organometallic Compounds
  • Meglumine
  • Meglumine Antimoniate
  • Antimony
Topics
  • Animals
  • Antimony (therapeutic use)
  • Cricetinae
  • Kupffer Cells (metabolism, parasitology)
  • Leishmania (physiology)
  • Leishmaniasis, Visceral (drug therapy, parasitology)
  • Liposomes (administration & dosage, metabolism)
  • Lysosomes (metabolism)
  • Macrophages (metabolism, parasitology)
  • Male
  • Meglumine
  • Meglumine Antimoniate
  • Mesocricetus
  • Microscopy, Electron
  • Organometallic Compounds
  • Phagocytosis
  • Spleen (parasitology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: